Status:
COMPLETED
EPASS Versus Uncovered Duodenal Stent for Unresectable Malignant Gastric Outlet Obstruction.
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Gastric Outlet Obstruction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Surgical gastrojejunostomy is the conventional treatment for palliating patients suffering from of inoperable malignant gastric outlet obstruction (GOO). Although, the procedure is associated with a h...
Detailed Description
In recent years, SEMSs have provided an attractive alternative to surgery for palliation of malignant gastric outlet obstruction. Several studies have assessed the clinical and technical success rates...
Eligibility Criteria
Inclusion
- Consecutive patients ≥ 18 years old
- Confirmed unresectable distal gastric or duodenal or pancreatico-biliary malignancies
- Suffering from gastric outlet obstruction with a gastric outlet obstruction score of ≤ 1
- Performance status ECOG ≤3
Exclusion
- Prior metallic stent placement
- Severe comorbidities precluding the endoscopic procedure (such as cardiopulmonary disease, sepsis, or a bleeding disorder)
- Life expectancy of less than 1 month
- History of gastric surgery
- Linitus plastic
- Multiple-level bowel obstruction confirmed on radiographic studies such as small bowel series or abdominal computed tomography
- Coagulation disorders
- Pregnancy
- Unable to give informed consent
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2022
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT03823690
Start Date
February 1 2020
End Date
May 30 2022
Last Update
August 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, Prince of Wales Hospital
Hong Kong, Hong Kong